News and Events - ONWARD Medical N.V.

Year

08 Dec 22

ONWARD Reports Interim Clinical Outcomes for Implantable ARC Therapy Demonstrating Potential to Improve Blood Pressure Regulation after Spinal Cord Injury

Low blood pressure is a major issue for people with spinal cord injury that impacts cardiovascular health and quality of life ARC Therapy resulted in immediate improvement in blood pressure regulation in all study participants

21 Nov 22

ONWARD Awarded European Innovation Council Grant to Further Develop Brain-Computer Interface Technology; Company also Wins First Place in 2022 Brain-Computer Interface Awards

EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA—November 21, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence

10 Nov 22

ONWARD’s Research Partner .NeuroRestore Publishes Groundbreaking Paper Identifying Neurons that Restore Walking after Paralysis

Data from all nine participants in STIMO trial published in Nature Researchers identify specific neurons activated and remodeled by spinal cord stimulation that enable patients to walk

08 Nov 22

ONWARD Reports Third Quarter 2022 Highlights and Provides Business Update

Two additional Breakthrough Device Designations granted by U.S. FDA for ARC Therapy Strong financial position with €70 million in cash and cash equivalents as of September 30, 2022, expected to fund operations through year-end 2024

Pagination

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Next page
Last page

Upcoming Events

More events are coming soon.

Recent Presentations

Webcast – ONWARD’s presentation at The Stifel Healthcare Conference

November 15, 2022

ONWD – Company Presentation (November 2022)

November 8, 2022